AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 150 filers reported holding AKEBIA THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $388,146 | -70.9% | 380,535 | -34.4% | 0.00% | – |
| Q4 2021 | $1,334,000 | -19.7% | 580,106 | +1.2% | 0.00% | -100.0% |
| Q3 2021 | $1,662,000 | -24.4% | 572,999 | -1.2% | 0.00% | 0.0% |
| Q2 2021 | $2,198,000 | +25.7% | 580,010 | +12.2% | 0.00% | 0.0% |
| Q1 2021 | $1,749,000 | -66.2% | 516,743 | -0.1% | 0.00% | -50.0% |
| Q4 2020 | $5,171,000 | -69.1% | 517,043 | -69.1% | 0.00% | -66.7% |
| Q3 2020 | $16,719,000 | -21.7% | 1,671,866 | +6.3% | 0.01% | -33.3% |
| Q2 2020 | $21,361,000 | +89.7% | 1,572,940 | +5.9% | 0.01% | +80.0% |
| Q1 2020 | $11,263,000 | +3.2% | 1,485,856 | -14.0% | 0.01% | +25.0% |
| Q4 2019 | $10,916,000 | +62.5% | 1,727,283 | +0.8% | 0.00% | +33.3% |
| Q3 2019 | $6,717,000 | -14.8% | 1,713,506 | +5.2% | 0.00% | 0.0% |
| Q2 2019 | $7,885,000 | – | 1,629,028 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 4,652,561 | $13,027,000 | 5.13% |
| Orchard Capital Management, LLC | 857,138 | $2,400,000 | 1.02% |
| Nantahala Capital Management | 7,040,487 | $19,713,000 | 0.61% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 209,040 | $585,000 | 0.18% |
| Woodline Partners LP | 2,382,522 | $6,671,000 | 0.18% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,546,169 | $4,329,000 | 0.15% |
| Virtus ETF Advisers LLC | 92,771 | $260,000 | 0.11% |
| Jump Financial, LLC | 155,583 | $435,000 | 0.07% |
| GSA CAPITAL PARTNERS LLP | 128,626 | $360,000 | 0.06% |
| Anson Funds Management LP | 95,342 | $267,000 | 0.05% |